Common Stock, Shares, Outstanding of HERBALIFE LTD. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
HERBALIFE LTD. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • HERBALIFE LTD. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 103,300,000, a 2.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

HERBALIFE LTD. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 103,300,000 +2,100,000 +2.1% 31 Dec 2025 10-K 18 Feb 2026 2025 FY
Q3 2025 103,200,000 +2,500,000 +2.5% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 103,100,000 +2,400,000 +2.4% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 101,600,000 +1,800,000 +1.8% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 101,200,000 +2,000,000 +2% 31 Dec 2024 10-K 18 Feb 2026 2025 FY
Q3 2024 100,700,000 +1,700,000 +1.7% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 100,700,000 +1,800,000 +1.8% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 99,800,000 +1,100,000 +1.1% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 99,200,000 +1,300,000 +1.3% 31 Dec 2023 10-K 18 Feb 2026 2025 FY
Q3 2023 99,000,000 +1,200,000 +1.2% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 98,900,000 +1,100,000 +1.1% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 98,700,000 -100,000 -0.1% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 97,900,000 -2,900,000 -2.9% 31 Dec 2022 10-K 19 Feb 2025 2024 FY
Q3 2022 97,800,000 -5,100,000 -5% 30 Sep 2022 10-Q 31 Oct 2022 2022 Q3
Q2 2022 97,800,000 -8,500,000 -8% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 98,800,000 -9,200,000 -8.5% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 100,800,000 -19,300,000 -16% 31 Dec 2021 10-K 14 Feb 2024 2023 FY
Q3 2021 102,900,000 -18,600,000 -15% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 106,300,000 -31,200,000 -23% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 108,000,000 -29,700,000 -22% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 120,100,000 -17,300,000 -13% 31 Dec 2020 10-K 14 Feb 2023 2022 FY
Q3 2020 121,500,000 -15,700,000 -11% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 137,500,000 -3,700,000 -2.6% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 137,700,000 -3,400,000 -2.4% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 137,400,000 -5,400,000 -3.8% 31 Dec 2019 10-K 23 Feb 2022 2021 FY
Q3 2019 137,200,000 -8,900,000 -6.1% 30 Sep 2019 10-Q 29 Oct 2019 2019 Q3
Q2 2019 141,200,000 -5,900,000 -4% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 141,100,000 +58,000,000 +70% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 142,800,000 -21,900,000 -13% 31 Dec 2018 10-K 17 Feb 2021 2020 FY
Q3 2018 146,100,000 +56,800,000 +64% 30 Sep 2018 10-Q 30 Oct 2018 2018 Q3
Q2 2018 147,100,000 +56,900,000 +63% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 83,100,000 -9,100,000 -9.9% 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 164,700,000 -21,600,000 -12% 31 Dec 2017 10-K 18 Feb 2020 2019 FY
Q3 2017 89,300,000 -3,800,000 -4.1% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 90,200,000 -2,800,000 -3% 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 92,200,000 -600,000 -0.65% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 186,300,000 +93,600,000 +101% 31 Dec 2016 10-K 19 Feb 2019 2018 FY
Q3 2016 93,100,000 +500,000 +0.54% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 93,000,000 +500,000 +0.54% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 92,800,000 +300,000 +0.32% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 92,700,000 +500,000 +0.54% 31 Dec 2015 10-K 22 Feb 2018 2017 FY
Q3 2015 92,600,000 +700,000 +0.76% 30 Sep 2015 10-Q 03 Nov 2015 2015 Q3
Q2 2015 92,500,000 +700,000 +0.76% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 92,500,000 -8,800,000 -8.7% 31 Mar 2015 10-Q 05 May 2015 2015 Q1
Q4 2014 92,200,000 -8,900,000 -8.8% 31 Dec 2014 10-K 23 Feb 2017 2016 FY
Q3 2014 91,900,000 -9,400,000 -9.3% 30 Sep 2014 10-Q 03 Nov 2014 2014 Q3
Q2 2014 91,800,000 -11,200,000 -11% 30 Jun 2014 10-Q 28 Jul 2014 2014 Q2
Q1 2014 101,300,000 -1,700,000 -1.6% 31 Mar 2014 10-Q 28 Apr 2014 2014 Q1
Q4 2013 101,100,000 -5,800,000 -5.4% 31 Dec 2013 10-K 25 Feb 2016 2015 FY
Q3 2013 101,300,000 -6,600,000 -6.1% 30 Sep 2013 10-Q/A 16 Dec 2013 2013 Q3
Q2 2013 103,000,000 -8,800,000 -7.9% 30 Jun 2013 10-Q/A 16 Dec 2013 2013 Q2
Q1 2013 103,000,000 -13,600,000 -12% 31 Mar 2013 10-Q/A 16 Dec 2013 2013 Q1
Q4 2012 106,900,000 -8,900,000 -7.7% 31 Dec 2012 10-K 26 Feb 2015 2014 FY
Q3 2012 107,900,000 -8,200,000 -7.1% 30 Sep 2012 10-Q 29 Oct 2012 2012 Q3
Q2 2012 111,800,000 -6,400,000 -5.4% 30 Jun 2012 10-Q 30 Jul 2012 2012 Q2
Q1 2012 116,600,000 +57,200,000 +96% 31 Mar 2012 10-Q 30 Apr 2012 2012 Q1
Q4 2011 115,800,000 -2,000,000 -1.7% 31 Dec 2011 10-K 18 Feb 2014 2013 FY
Q3 2011 116,100,000 +56,900,000 +96% 30 Sep 2011 10-Q 31 Oct 2011 2011 Q3
Q2 2011 118,200,000 +59,100,000 +100% 30 Jun 2011 10-Q 01 Aug 2011 2011 Q2
Q1 2011 59,400,000 31 Mar 2011 10-Q 02 May 2011 2011 Q1
Q4 2010 117,800,000 31 Dec 2010 10-K/A 16 Dec 2013 2012 FY
Q3 2010 59,200,000 30 Sep 2010 10-Q 01 Nov 2010 2010 Q3
Q2 2010 59,100,000 30 Jun 2010 10-Q 02 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.